Correlation Between Tscan Therapeutics and Enveric Biosciences

Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tscan Therapeutics and Enveric Biosciences, you can compare the effects of market volatilities on Tscan Therapeutics and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Enveric Biosciences.

Diversification Opportunities for Tscan Therapeutics and Enveric Biosciences

0.07

Correlation Coefficient

Tscan Therapeutics  Enveric Biosciences

Significant diversification

The 3 months correlation between Tscan and Enveric is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Enveric Biosciences go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and Enveric Biosciences

Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 1.63 times more return on investment than Enveric Biosciences. However, Tscan Therapeutics is 1.63 times more volatile than Enveric Biosciences. It trades about 0.12 of its potential returns per unit of risk. Enveric Biosciences is currently generating about -0.03 per unit of risk. If you would invest  127.00  in Tscan Therapeutics on May 9, 2025 and sell it today you would earn a total of  48.00  from holding Tscan Therapeutics or generate 37.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Tscan Therapeutics  vs.  Enveric Biosciences

Tscan Therapeutics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Tscan Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Tscan Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Enveric Biosciences

Risk-Adjusted Performance

Weakest

Over the last 90 days Enveric Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Tscan Therapeutics and Enveric Biosciences

The main advantage of trading using opposite Tscan Therapeutics and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.

The idea behind Tscan Therapeutics and Enveric Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.